Senate
Study
Bill
1243
-
Introduced
SENATE
FILE
_____
BY
(PROPOSED
COMMITTEE
ON
WAYS
AND
MEANS
BILL
BY
CHAIRPERSON
BOLKCOM)
A
BILL
FOR
An
Act
creating
the
medical
cannabis
Act
and
providing
for
1
civil
and
criminal
penalties
and
fees.
2
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
3
TLSB
2576XC
(4)
86
rh/rj
S.F.
_____
Section
1.
Section
124.401,
subsection
5,
unnumbered
1
paragraph
3,
Code
2015,
is
amended
to
read
as
follows:
2
A
person
may
knowingly
or
intentionally
recommend,
possess,
3
use,
dispense,
deliver,
transport,
or
administer
cannabidiol
4
medical
cannabis
if
the
recommendation,
possession,
use,
5
dispensing,
delivery,
transporting,
or
administering
is
in
6
accordance
with
the
provisions
of
chapter
124D
124E
.
For
7
purposes
of
this
paragraph,
“cannabidiol”
“medical
cannabis”
8
means
the
same
as
defined
in
section
124D.2
124E.2
.
9
Sec.
2.
NEW
SECTION
.
124E.1
Short
title.
10
This
chapter
shall
be
known
and
may
be
cited
as
the
“Medical
11
Cannabis
Act”
.
12
Sec.
3.
NEW
SECTION
.
124E.2
Definitions.
13
As
used
in
this
chapter:
14
1.
“Debilitating
medical
condition”
means
any
of
the
15
following:
16
a.
Cancer.
17
b.
Multiple
sclerosis.
18
c.
Epilepsy.
19
d.
AIDS
or
HIV
as
defined
in
section
141A.1.
20
e.
Glaucoma.
21
f.
Hepatitis
C.
22
g.
Crohn’s
disease
or
ulcerative
colitis.
23
h.
Amyotrophic
lateral
sclerosis.
24
i.
Ehlers-danlos
syndrome.
25
j.
Post-traumatic
stress
syndrome.
26
k.
Any
other
chronic
or
debilitating
disease
or
medical
27
condition
or
its
medical
treatment
approved
by
the
department
28
pursuant
to
rule.
29
2.
“Department”
means
the
department
of
public
health.
30
3.
“Disqualifying
felony
offense”
means
a
violation
under
31
federal
or
state
law
of
a
felony
offense,
which
has
as
an
32
element
the
possession,
use,
or
distribution
of
a
controlled
33
substance,
as
defined
in
21
U.S.C.
§802(6).
34
4.
“Enclosed,
locked
facility”
means
a
closet,
room,
35
-1-
LSB
2576XC
(4)
86
rh/rj
1/
23
S.F.
_____
greenhouse,
or
other
enclosed
area
equipped
with
locks
or
other
1
security
devices
that
permit
access
only
by
a
cardholder.
2
5.
“Health
care
practitioner”
means
an
individual
licensed
3
under
chapter
148
to
practice
medicine
and
surgery
or
4
osteopathic
medicine
and
surgery,
a
physician
assistant
5
licensed
under
chapter
148C,
or
an
advanced
registered
nurse
6
practitioner
licensed
pursuant
to
chapter
152
or
152E.
7
6.
“Medical
cannabis”
means
any
species
of
the
genus
8
cannabis
plant,
or
any
mixture
or
preparation
of
them,
9
including
whole
plant
extracts
and
resins.
10
7.
“Medical
cannabis
dispensary”
means
an
entity
licensed
11
under
section
124E.6
that
dispenses
and
acquires,
possesses,
12
cultivates,
or
manufactures
medical
cannabis
pursuant
to
this
13
chapter.
14
8.
“Medical
cannabis
manufacturer”
means
an
entity
licensed
15
by
the
department
to
manufacture
and
to
possess,
cultivate,
16
transport,
supply,
or
dispense
medical
cannabis
pursuant
to
the
17
provisions
of
this
chapter.
18
9.
“Primary
caregiver”
means
a
person,
at
least
eighteen
19
years
of
age,
who
has
been
designated
by
a
patient’s
health
20
care
practitioner
or
a
person
having
custody
of
a
patient,
as
21
a
necessary
caretaker
taking
responsibility
for
managing
the
22
well-being
of
the
patient
with
respect
to
the
use
of
medical
23
cannabis
pursuant
to
the
provisions
of
this
chapter.
24
10.
“Written
certification”
means
a
document
signed
by
a
25
health
care
practitioner,
with
whom
the
patient
has
established
26
a
patient-provider
relationship,
which
states
that
the
patient
27
has
a
debilitating
medical
condition
and
identifies
that
28
condition
and
provides
any
other
relevant
information.
29
Sec.
4.
NEW
SECTION
.
124E.3
Health
care
practitioner
30
certification
——
duties.
31
1.
Prior
to
a
patient’s
submission
of
an
application
for
a
32
medical
cannabis
card
pursuant
to
section
124E.4,
a
health
care
33
practitioner
shall
do
all
of
the
following:
34
a.
Determine,
in
the
health
care
practitioner’s
medical
35
-2-
LSB
2576XC
(4)
86
rh/rj
2/
23
S.F.
_____
judgment,
whether
the
patient
whom
the
health
care
practitioner
1
has
examined
and
treated
suffers
from
a
debilitating
medical
2
condition
that
qualifies
for
the
use
of
medical
cannabis
under
3
this
chapter,
and
if
so
determined,
provide
the
patient
with
a
4
written
certification
of
that
diagnosis.
5
b.
Provide
explanatory
information
as
provided
by
the
6
department
to
the
patient
about
the
therapeutic
use
of
medical
7
cannabis.
8
2.
Determine,
on
an
annual
basis,
if
the
patient
continues
9
to
suffer
from
a
debilitating
medical
condition
and,
if
so,
10
issue
the
patient
a
new
certification
of
that
diagnosis.
11
3.
Otherwise
comply
with
all
requirements
established
by
12
the
department
pursuant
to
rule.
13
4.
A
health
care
practitioner
may
provide,
but
has
no
duty
14
to
provide,
a
written
certification
pursuant
to
this
section.
15
Sec.
5.
NEW
SECTION
.
124E.4
Medical
cannabis
registration
16
card.
17
1.
Issuance
to
patient.
The
department
may
approve
the
18
issuance
of
a
medical
cannabis
registration
card
by
the
19
department
of
transportation
to
a
patient
who:
20
a.
Is
at
least
eighteen
years
of
age.
21
b.
Is
a
permanent
resident
of
this
state.
22
c.
Submits
a
written
certification
to
the
department
signed
23
by
the
patient’s
health
care
practitioner
that
the
patient
is
24
suffering
from
a
debilitating
medical
condition.
25
d.
Submits
an
application
to
the
department,
on
a
form
26
created
by
the
department,
in
consultation
with
the
department
27
of
transportation,
that
contains
all
of
the
following:
28
(1)
The
patient’s
full
name,
Iowa
residence
address,
date
29
of
birth,
and
telephone
number.
30
(2)
A
copy
of
the
patient’s
valid
photo
identification.
31
(3)
Full
name,
address,
and
telephone
number
of
the
32
patient’s
health
care
practitioner.
33
(4)
Full
name,
residence
address,
date
of
birth,
and
34
telephone
number
of
each
primary
caregiver
of
the
patient,
if
35
-3-
LSB
2576XC
(4)
86
rh/rj
3/
23
S.F.
_____
any.
1
(5)
Any
other
information
required
by
rule.
2
2.
Patient
card
contents.
A
medical
cannabis
registration
3
card
issued
to
a
patient
by
the
department
of
transportation
4
pursuant
to
subsection
1
shall
contain,
at
a
minimum,
all
of
5
the
following:
6
a.
The
patient’s
full
name,
Iowa
residence
address,
and
date
7
of
birth.
8
b.
The
patient’s
photo.
9
c.
The
date
of
issuance
and
expiration
date
of
the
10
registration
card.
11
d.
Any
other
information
required
by
rule.
12
3.
Issuance
to
primary
caregiver.
For
a
patient
in
a
13
primary
caregiver’s
care,
the
department
may
approve
the
14
issuance
of
a
medical
cannabis
registration
card
by
the
15
department
of
transportation
to
the
primary
caregiver
who:
16
a.
Is
at
least
eighteen
years
of
age.
17
b.
Submits
a
written
certification
to
the
department
signed
18
by
the
patient’s
health
care
practitioner
that
the
patient
in
19
the
primary
caregiver’s
care
is
suffering
from
a
debilitating
20
medical
condition.
21
c.
Submits
an
application
to
the
department,
on
a
form
22
created
by
the
department,
in
consultation
with
the
department
23
of
transportation,
that
contains
all
of
the
following:
24
(1)
The
primary
caregiver’s
full
name,
residence
address,
25
date
of
birth,
and
telephone
number.
26
(2)
The
patient’s
full
name.
27
(3)
A
copy
of
the
primary
caregiver’s
valid
photo
28
identification.
29
(4)
Full
name,
address,
and
telephone
number
of
the
30
patient’s
health
care
practitioner.
31
(5)
Any
other
information
required
by
rule.
32
4.
Primary
caregiver
card
contents.
A
medical
cannabis
33
registration
card
issued
by
the
department
of
transportation
to
34
a
primary
caregiver
pursuant
to
subsection
3
shall
contain,
at
35
-4-
LSB
2576XC
(4)
86
rh/rj
4/
23
S.F.
_____
a
minimum,
all
of
the
following:
1
a.
The
primary
caregiver’s
full
name,
residence
address,
and
2
date
of
birth.
3
b.
The
primary
caregiver’s
photo.
4
c.
The
date
of
issuance
and
expiration
date
of
the
5
registration
card.
6
d.
The
full
name
of
each
patient
in
the
primary
caregiver’s
7
care.
8
e.
Any
other
information
required
by
rule.
9
5.
Expiration
date
of
card.
A
medical
cannabis
registration
10
card
issued
pursuant
to
this
section
shall
expire
one
year
11
after
the
date
of
issuance
and
may
be
renewed.
12
6.
Card
issuance
——
department
of
transportation.
The
13
department
may
enter
into
a
chapter
28E
agreement
with
the
14
department
of
transportation
to
facilitate
the
issuance
of
15
medical
cannabis
registration
cards
pursuant
to
subsections
1
16
and
3.
17
Sec.
6.
NEW
SECTION
.
124E.5
Medical
advisory
board
——
18
duties.
19
1.
No
later
than
August
15,
2015,
the
director
of
public
20
health
shall
establish
a
medical
advisory
board
consisting
21
of
nine
practitioners
representing
the
fields
of
neurology,
22
pain
management,
gastroenterology,
oncology,
psychiatry,
23
infectious
disease,
family
medicine,
gynecology,
and
pharmacy.
24
The
practitioners
shall
be
nationally
board-certified
in
their
25
area
of
specialty
and
knowledgeable
about
the
use
of
medical
26
cannabis.
27
2.
A
quorum
of
the
advisory
board
shall
consist
of
five
28
members.
29
3.
The
duties
of
the
advisory
board
shall
include
but
not
be
30
limited
to
the
following:
31
a.
Reviewing
and
recommending
to
the
department
for
32
approval
additional
chronic
or
debilitating
diseases
or
33
medical
conditions
or
their
treatments
as
debilitating
medical
34
conditions
that
qualify
for
the
use
of
medical
cannabis
under
35
-5-
LSB
2576XC
(4)
86
rh/rj
5/
23
S.F.
_____
this
chapter.
1
b.
Accepting
and
reviewing
petitions
to
add
chronic
or
2
debilitating
diseases
or
medical
conditions
or
their
medical
3
treatments
to
the
list
of
debilitating
medical
conditions
that
4
qualify
for
the
use
of
medical
cannabis
under
this
chapter.
5
c.
Advising
the
department
regarding
the
location
of
6
medical
cannabis
dispensaries
throughout
the
state,
the
form
7
and
quantity
of
allowable
medical
cannabis
to
be
dispensed
8
to
a
patient
or
primary
caregiver,
and
the
general
oversight
9
of
medical
cannabis
manufacturers
and
medical
cannabis
10
dispensaries
in
this
state.
11
d.
Convening
at
least
twice
per
year
to
conduct
public
12
hearings
and
to
evaluate
petitions,
which
shall
be
maintained
13
as
confidential
personal
health
information,
to
add
chronic
or
14
debilitating
diseases
or
medical
conditions
or
their
medical
15
treatments
to
the
list
of
debilitating
medical
conditions
that
16
qualify
for
the
use
of
medical
cannabis
under
this
chapter.
17
Sec.
7.
NEW
SECTION
.
124E.6
Medical
cannabis
manufacturer
18
licensure.
19
1.
a.
The
department
shall
license
four
medical
cannabis
20
manufacturers
to
manufacture
medical
cannabis
within
this
state
21
consistent
with
the
provisions
of
this
chapter
by
December
22
1,
2015.
The
department
shall
license
new
medical
cannabis
23
manufacturers
or
relicense
the
existing
medical
cannabis
24
manufacturers
by
December
1
of
each
year.
25
b.
Information
submitted
during
the
application
process
26
shall
be
confidential
until
the
medical
cannabis
manufacturer
27
is
licensed
by
the
department
unless
otherwise
protected
from
28
disclosure
under
state
or
federal
law.
29
2.
As
a
condition
for
licensure,
a
medical
cannabis
30
manufacturer
must
agree
to
begin
supplying
medical
cannabis
to
31
patients
by
July
1,
2016.
32
3.
The
department
shall
consider
the
following
factors
in
33
determining
whether
to
license
a
medical
cannabis
manufacturer:
34
a.
The
technical
expertise
of
the
medical
cannabis
35
-6-
LSB
2576XC
(4)
86
rh/rj
6/
23
S.F.
_____
manufacturer
in
medical
cannabis.
1
b.
The
qualifications
of
the
medical
cannabis
manufacturer’s
2
employees.
3
c.
The
long-term
financial
stability
of
the
medical
cannabis
4
manufacturer.
5
d.
The
ability
to
provide
appropriate
security
measures
on
6
the
premises
of
the
medical
cannabis
manufacturer.
7
e.
Whether
the
medical
cannabis
manufacturer
has
8
demonstrated
an
ability
to
meet
certain
medical
cannabis
9
production
needs
for
medical
use
in
the
manner
determined
by
10
the
department
pursuant
to
rule.
11
f.
The
medical
cannabis
manufacturer’s
projection
and
12
ongoing
assessment
of
fees
on
patients
with
debilitating
13
medical
conditions.
14
4.
The
department
shall
require
each
medical
cannabis
15
manufacturer
to
contract
with
the
state
hygienic
laboratory
16
at
the
university
of
Iowa
in
Iowa
City
to
test
the
medical
17
cannabis
produced
by
the
manufacturer.
The
department
shall
18
require
that
the
laboratory
report
testing
results
to
the
19
manufacturer
in
a
manner
determined
by
the
department
pursuant
20
to
rule.
21
5.
Each
entity
submitting
an
application
for
licensure
as
a
22
medical
cannabis
manufacturer
shall
pay
an
application
fee
of
23
seven
thousand
five
hundred
dollars
to
the
department.
24
Sec.
8.
NEW
SECTION
.
124E.7
Medical
cannabis
manufacturers
25
——
medical
cannabis
dispensaries.
26
1.
a.
A
medical
cannabis
manufacturer
shall
operate
three
27
medical
cannabis
dispensaries,
which
may
include
the
medical
28
cannabis
manufacturer’s
single
location
for
manufacturing
and
29
cultivating,
harvesting,
packaging,
or
processing.
30
b.
A
medical
cannabis
manufacturer
shall
begin
dispensing
31
medical
cannabis
from
at
least
one
medical
cannabis
dispensary
32
by
July
1,
2016.
33
c.
The
medical
cannabis
dispensaries
shall
be
located
based
34
on
geographical
need
throughout
the
state
to
improve
patient
35
-7-
LSB
2576XC
(4)
86
rh/rj
7/
23
S.F.
_____
access.
1
d.
A
medical
cannabis
manufacturer
shall
disclose
the
2
proposed
locations
for
the
medical
cannabis
dispensaries
to
the
3
department
during
the
licensure
process.
4
e.
A
medical
cannabis
manufacturer
shall
operate
only
one
5
location
where
all
manufacturing
and
cultivating,
harvesting,
6
packaging,
or
processing
shall
be
conducted.
The
other
medical
7
cannabis
dispensaries
may
dispense
medical
cannabis
pursuant
8
to
the
provisions
of
this
chapter
but
shall
not
dispense
any
9
medical
cannabis
in
a
form
or
quantity
other
than
the
form
or
10
quantity
allowed
by
the
department
pursuant
to
rule.
11
2.
A
medical
cannabis
manufacturer
shall
contract
with
the
12
state
hygienic
laboratory
at
the
university
of
Iowa
in
Iowa
13
City
for
purposes
of
testing
the
medical
cannabis
manufactured
14
by
the
medical
cannabis
manufacturer
as
to
content,
15
contamination,
and
consistency.
The
cost
of
all
laboratory
16
testing
shall
be
paid
by
the
medical
cannabis
manufacturer.
17
3.
The
operating
documents
of
a
medical
cannabis
18
manufacturer
shall
include
all
of
the
following:
19
a.
Procedures
for
the
oversight
of
the
medical
cannabis
20
manufacturer
and
procedures
to
ensure
accurate
record
keeping.
21
b.
Procedures
for
the
implementation
of
appropriate
security
22
measures
to
deter
and
prevent
the
theft
of
medical
cannabis
and
23
unauthorized
entrance
into
areas
containing
medical
cannabis.
24
4.
A
medical
cannabis
manufacturer
shall
implement
security
25
requirements,
including
requirements
for
protection
of
each
26
location
by
a
fully
operational
security
alarm
system,
facility
27
access
controls,
perimeter
intrusion
detection
systems,
and
a
28
personnel
identification
system.
29
5.
A
medical
cannabis
manufacturer
shall
not
share
30
office
space
with,
refer
patients
to,
or
have
any
financial
31
relationship
with
a
health
care
practitioner.
32
6.
A
medical
cannabis
manufacturer
shall
not
permit
any
33
person
to
consume
medical
cannabis
on
the
property
of
the
34
medical
cannabis
manufacturer.
35
-8-
LSB
2576XC
(4)
86
rh/rj
8/
23
S.F.
_____
7.
A
medical
cannabis
manufacturer
is
subject
to
reasonable
1
inspection
by
the
department.
2
8.
A
medical
cannabis
manufacturer
shall
not
employ
3
a
person
under
twenty-one
years
of
age
or
who
has
been
4
convicted
of
a
disqualifying
felony
offense.
An
employee
5
of
a
medical
cannabis
manufacturer
shall
be
subject
to
a
6
background
investigation
conducted
by
the
division
of
criminal
7
investigation
of
the
department
of
public
safety
and
a
national
8
criminal
history
background
check.
9
9.
A
medical
cannabis
manufacturer
shall
not
operate
in
10
any
location,
whether
for
dispensing
or
for
manufacturing,
11
cultivating,
harvesting,
packaging,
or
processing,
within
one
12
thousand
feet
of
a
public
or
private
school
existing
before
the
13
date
of
the
medical
cannabis
manufacturer’s
licensure
by
the
14
department.
15
10.
A
medical
cannabis
manufacturer
shall
comply
with
16
reasonable
restrictions
set
by
the
department
relating
to
17
signage,
marketing,
display,
and
advertising
of
medical
18
cannabis.
19
Sec.
9.
NEW
SECTION
.
124E.8
Medical
cannabis
manufacturer
20
——
production
and
dispensation.
21
1.
Production.
22
a.
A
medical
cannabis
manufacturer
shall
provide
a
reliable
23
and
ongoing
supply
of
medical
cannabis
for
all
patients
served
24
pursuant
to
this
chapter.
25
b.
All
manufacturing,
cultivating,
harvesting,
26
manufacturing,
packaging,
and
processing
of
medical
cannabis
27
shall
take
place
in
an
enclosed,
locked
facility
at
a
physical
28
address
provided
to
the
department
during
the
licensure
29
process.
30
2.
Dispensation.
Prior
to
dispensing
of
any
medical
31
cannabis,
the
medical
cannabis
manufacturer
shall
do
all
of
the
32
following:
33
a.
Verify
that
the
medical
cannabis
manufacturer
has
34
received
a
valid
medical
cannabis
registration
card
from
a
35
-9-
LSB
2576XC
(4)
86
rh/rj
9/
23
S.F.
_____
patient
or
a
patient’s
primary
caregiver,
if
applicable.
1
b.
Assign
a
tracking
number
to
any
medical
cannabis
2
dispensed
from
the
manufacturer.
3
c.
Properly
package
medical
cannabis
in
compliance
with
4
federal
law
regarding
child
resistant
packaging
and
exemptions
5
for
packaging
for
elderly
patients,
and
label
medical
cannabis
6
with
a
list
of
all
active
ingredients
and
individually
7
identifying
information,
including
all
of
the
following:
8
(1)
The
name
and
date
of
birth
of
the
patient
and
the
9
patient’s
primary
caregiver,
if
appropriate.
10
(2)
The
medical
cannabis
registration
card
numbers
of
the
11
patient
and
the
patient’s
primary
caregiver,
if
applicable.
12
(3)
The
chemical
composition
of
the
medical
cannabis.
13
Sec.
10.
NEW
SECTION
.
124E.9
Department
duties
——
rules.
14
1.
a.
The
department
shall
maintain
a
confidential
file
15
of
the
names
of
each
patient
to
or
for
whom
the
department
16
issues
a
medical
cannabis
registration
card
and
the
name
of
17
each
primary
caregiver
to
whom
the
department
issues
a
medical
18
cannabis
registration
card
under
section
124E.4.
19
b.
Individual
names
contained
in
the
file
shall
be
20
confidential
and
shall
not
be
subject
to
disclosure,
except
as
21
provided
in
subparagraph
(1).
22
(1)
Information
in
the
confidential
file
maintained
23
pursuant
to
paragraph
“a”
may
be
released
on
an
individual
basis
24
to
the
following
persons
under
the
following
circumstances:
25
(a)
To
authorized
employees
or
agents
of
the
department
and
26
the
department
of
transportation
as
necessary
to
perform
the
27
duties
of
the
department
and
the
department
of
transportation
28
pursuant
to
this
chapter.
29
(b)
To
authorized
employees
of
state
or
local
law
30
enforcement
agencies,
but
only
for
the
purpose
of
verifying
31
that
a
person
is
lawfully
in
possession
of
a
medical
cannabis
32
registration
card
issued
pursuant
to
this
chapter.
33
(c)
To
authorized
employees
of
a
medical
cannabis
34
manufacturer,
but
only
for
the
purpose
of
verifying
that
35
-10-
LSB
2576XC
(4)
86
rh/rj
10/
23
S.F.
_____
a
person
is
lawfully
in
possession
of
a
medical
cannabis
1
registration
card
issued
pursuant
to
this
chapter.
2
(2)
Release
of
information
pursuant
to
subparagraph
3
(1)
shall
be
consistent
with
the
federal
Health
Insurance
4
Portability
and
Accountability
Act
of
1996,
Pub.
L.
No.
5
104-191.
6
2.
The
department
shall
adopt
rules
pursuant
to
chapter
7
17A
to
administer
this
chapter
which
shall
include
but
not
be
8
limited
to
rules
to
do
all
of
the
following:
9
a.
Govern
the
manner
in
which
the
department
shall
consider
10
applications
for
new
and
renewal
medical
cannabis
registration
11
cards.
12
b.
Identify
criteria
and
set
forth
procedures
for
13
including
additional
chronic
or
debilitating
diseases
or
14
medical
conditions
or
their
medical
treatments
on
the
list
of
15
debilitating
medical
conditions
that
qualify
for
the
use
of
16
medical
cannabis.
Procedures
shall
include
a
petition
process
17
and
shall
allow
for
public
comment
and
public
hearings
before
18
the
medical
advisory
board.
19
c.
Set
forth
additional
chronic
or
debilitating
diseases
or
20
medical
conditions
or
their
medical
treatments
for
inclusion
21
on
the
list
of
debilitating
medical
conditions
that
qualify
22
for
the
use
of
medical
cannabis
as
recommended
by
the
medical
23
advisory
board.
24
d.
Establish
the
form
and
quantity
of
medical
cannabis
25
allowed
to
be
dispensed
to
a
patient
or
primary
caregiver
26
pursuant
to
this
chapter.
The
form
and
quantity
of
medical
27
cannabis
shall
be
appropriate
to
serve
the
medical
needs
of
28
patients
with
debilitating
conditions.
29
e.
Establish
requirements
for
the
licensure
of
medical
30
cannabis
manufacturers
and
set
forth
procedures
for
medical
31
cannabis
manufacturers
to
obtain
licenses.
32
f.
Develop
a
dispensing
system
for
medical
cannabis
within
33
this
state
that
provides
for
all
of
the
following:
34
(1)
Medical
cannabis
manufacturing
facilities
within
this
35
-11-
LSB
2576XC
(4)
86
rh/rj
11/
23
S.F.
_____
state
housed
on
secured
grounds
and
operated
by
licensed
1
medical
cannabis
manufacturers.
2
(2)
The
dispensing
of
medical
cannabis
to
patients
and
3
their
primary
caregivers
to
occur
at
locations
designated
by
4
the
department.
5
g.
Establish
medical
cannabis
registration
card
application
6
and
renewal
fees.
7
h.
Specify
and
implement
procedures
that
address
public
8
safety
including
security
procedures
and
product
quality
9
including
measures
to
ensure
contaminant-free
cultivation
of
10
medical
cannabis,
safety,
and
labeling.
11
Sec.
11.
NEW
SECTION
.
124E.10
Reciprocity.
12
A
valid
medical
cannabis
registration
card,
or
its
13
equivalent,
issued
under
the
laws
of
another
state
that
allows
14
an
out-of-state
patient
to
possess
or
use
medical
cannabis
in
15
the
jurisdiction
of
issuance
shall
have
the
same
force
and
16
effect
as
a
valid
medical
cannabis
registration
card
issued
17
pursuant
to
this
chapter,
except
that
an
out-of-state
patient
18
in
this
state
shall
not
obtain
medical
cannabis
from
a
medical
19
cannabis
dispensary
in
this
state.
20
Sec.
12.
NEW
SECTION
.
124E.11
Use
of
medical
cannabis
——
21
smoking
prohibited.
22
A
patient
shall
not
consume
medical
cannabis
possessed
or
23
used
as
authorized
by
this
chapter
by
smoking
medical
cannabis.
24
Sec.
13.
NEW
SECTION
.
124E.12
Use
of
medical
cannabis
——
25
affirmative
defenses.
26
1.
A
health
care
practitioner,
including
any
authorized
27
agent
or
employee
thereof,
shall
not
be
subject
to
28
prosecution
for
the
unlawful
certification,
possession,
or
29
administration
of
marijuana
under
the
laws
of
this
state
for
30
activities
arising
directly
out
of
or
directly
related
to
the
31
certification
or
use
of
medical
cannabis
in
the
treatment
of
32
a
patient
diagnosed
with
a
debilitating
medical
condition
as
33
authorized
by
this
chapter.
34
2.
A
medical
cannabis
manufacturer,
including
any
35
-12-
LSB
2576XC
(4)
86
rh/rj
12/
23
S.F.
_____
authorized
agent
or
employee
thereof,
shall
not
be
subject
1
to
prosecution
for
manufacturing,
possessing,
cultivating,
2
harvesting,
packaging,
or
processing,
or
transporting,
3
supplying,
or
dispensing
medical
cannabis
pursuant
to
this
4
chapter.
5
3.
A
medical
cannabis
dispensary,
including
any
authorized
6
agent
or
employee
thereof,
shall
not
be
subject
to
prosecution
7
for
transporting,
supplying,
or
dispensing
medical
cannabis
8
pursuant
to
this
chapter.
9
a.
In
a
prosecution
for
the
unlawful
possession
of
marijuana
10
under
the
laws
of
this
state,
including
but
not
limited
to
11
chapters
124
and
453B,
it
is
an
affirmative
and
complete
12
defense
to
the
prosecution
that
the
patient
has
been
diagnosed
13
with
a
debilitating
medical
condition,
used
or
possessed
14
medical
cannabis
pursuant
to
a
certification
by
a
health
care
15
practitioner
as
authorized
under
this
chapter,
and,
for
a
16
patient
eighteen
years
of
age
or
older,
is
in
possession
of
a
17
valid
medical
cannabis
registration
card.
18
b.
In
a
prosecution
for
the
unlawful
possession
of
marijuana
19
under
the
laws
of
this
state,
including
but
not
limited
to
20
chapters
124
and
453B,
it
is
an
affirmative
and
complete
21
defense
to
the
prosecution
that
the
person
possessed
medical
22
cannabis
because
the
person
is
a
primary
caregiver
of
a
patient
23
who
has
been
diagnosed
with
a
debilitating
medical
condition
24
and
is
in
possession
of
a
valid
medical
cannabis
registration
25
card,
and
where
the
primary
caregiver’s
possession
of
the
26
medical
cannabis
is
on
behalf
of
the
patient
and
for
the
27
patient’s
use
only
as
authorized
under
this
chapter.
28
c.
If
a
patient
or
primary
caregiver
is
charged
with
the
29
commission
of
a
crime
and
is
not
in
possession
of
the
person’s
30
medical
cannabis
registration
card,
any
charge
or
charges
filed
31
against
the
person
shall
be
dismissed
by
the
court
if
the
32
person
produces
to
the
court
prior
to
or
at
the
person’s
trial
33
a
medical
cannabis
registration
card
issued
to
that
person
and
34
valid
at
the
time
the
person
was
charged.
35
-13-
LSB
2576XC
(4)
86
rh/rj
13/
23
S.F.
_____
4.
An
agency
of
this
state
or
a
political
subdivision
1
thereof,
including
any
law
enforcement
agency,
shall
not
remove
2
or
initiate
proceedings
to
remove
a
patient
under
the
age
3
of
eighteen
from
the
home
of
a
parent
based
solely
upon
the
4
parent’s
or
patient’s
possession
or
use
of
medical
cannabis
as
5
authorized
under
this
chapter.
6
Sec.
14.
NEW
SECTION
.
124E.13
Penalties.
7
1.
A
person
who
knowingly
or
intentionally
possesses
or
8
uses
medical
cannabis
in
violation
of
the
requirements
of
this
9
chapter
is
subject
to
the
penalties
provided
under
chapters
124
10
and
453B.
11
2.
A
medical
cannabis
manufacturer
shall
be
assessed
a
civil
12
penalty
of
up
to
one
thousand
dollars
per
violation
for
any
13
violation
of
this
chapter
in
addition
to
any
other
applicable
14
penalties.
15
Sec.
15.
EMERGENCY
RULES.
The
department
may
adopt
16
emergency
rules
under
section
17A.4,
subsection
3,
and
section
17
17A.5,
subsection
2,
paragraph
“b”,
to
implement
the
provisions
18
of
this
Act
and
the
rules
shall
be
effective
immediately
upon
19
filing
unless
a
later
date
is
specified
in
the
rules.
Any
20
rules
adopted
in
accordance
with
this
section
shall
also
be
21
published
as
a
notice
of
intended
action
as
provided
in
section
22
17A.4.
23
Sec.
16.
TRANSITION
PROVISIONS.
A
medical
cannabis
24
registration
card
issued
under
chapter
124D
prior
to
July
1,
25
2015,
remains
effective
and
continues
in
effect
as
issued
for
26
the
twelve-month
period
following
its
issuance.
This
Act
does
27
not
preclude
the
permit
holder
from
seeking
to
renew
the
permit
28
under
this
Act
prior
to
the
expiration
of
the
twelve-month
29
period.
30
Sec.
17.
REPORTS.
The
university
of
Iowa
Carver
college
of
31
medicine
and
college
of
pharmacy
shall,
on
or
before
July
1
of
32
each
year,
beginning
July
1,
2016,
submit
a
report
detailing
33
the
scientific
literature,
studies,
and
clinical
trials
34
regarding
the
use
of
medical
cannabis
on
patients
diagnosed
35
-14-
LSB
2576XC
(4)
86
rh/rj
14/
23
S.F.
_____
with
debilitating
medical
conditions
as
defined
in
this
Act
to
1
the
department
of
public
health
and
the
general
assembly.
2
Sec.
18.
REPEAL.
Chapter
124D,
Code
2015,
is
repealed.
3
EXPLANATION
4
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
5
the
explanation’s
substance
by
the
members
of
the
general
assembly.
6
This
bill
creates
the
medical
cannabis
Act
and
provides
for
7
civil
and
criminal
penalties
and
fees.
8
OVERVIEW.
The
bill
allows
a
patient
with
a
debilitating
9
medical
condition
who
receives
written
certification
from
10
the
patient’s
health
care
practitioner
that
the
patient
has
11
a
debilitating
medical
condition
and
who
submits
the
written
12
certification
along
with
an
application
to
the
department
of
13
public
health
(department)
for
a
medical
cannabis
registration
14
card
to
allow
for
the
lawful
use
of
medical
cannabis
to
treat
15
the
patient’s
debilitating
medical
condition.
A
patient
who
16
is
issued
a
medical
cannabis
registration
card
will
be
able
17
to
receive
medical
cannabis
directly
from
a
medical
cannabis
18
dispensary
in
this
state
operated
by
a
medical
cannabis
19
manufacturer
licensed
by
the
state.
20
DEFINITIONS.
The
bill
provides
the
following
definitions:
21
“Debilitating
medical
condition”
means
cancer,
multiple
22
sclerosis,
epilepsy,
AIDS
or
HIV,
glaucoma,
hepatitis
C,
23
Crohn’s
disease
or
ulcerative
colitis,
amyotrophic
lateral
24
sclerosis,
Ehlers-danlos
syndrome,
post-traumatic
stress
25
syndrome,
and
any
other
chronic
or
debilitating
disease
or
26
medical
condition
or
its
medical
treatment
approved
by
the
27
department
by
rule.
28
“Health
care
practitioner”
means
an
individual
licensed
29
under
Code
chapter
148
to
practice
medicine
and
surgery
30
or
osteopathic
medicine
and
surgery,
a
physician
assistant
31
licensed
under
Code
chapter
148C,
or
an
advanced
registered
32
nurse
practitioner
licensed
pursuant
to
Code
chapter
152
or
33
152E.
34
“Medical
cannabis”
means
any
species
of
the
genus
cannabis
35
-15-
LSB
2576XC
(4)
86
rh/rj
15/
23
S.F.
_____
plant,
or
any
mixture
or
preparation
of
them,
including
whole
1
plant
extracts
and
resins.
2
“Medical
cannabis
dispensary”
means
an
entity
licensed
under
3
the
bill
that
dispenses
and
acquires,
possesses,
cultivates,
or
4
manufactures
medical
cannabis
pursuant
to
the
bill.
5
“Medical
cannabis
manufacturer”
means
an
entity
licensed
6
by
the
department
to
manufacture
and
to
possess,
cultivate,
7
transport,
supply,
or
dispense
medical
cannabis
pursuant
to
the
8
provisions
of
this
chapter.
9
“Primary
caregiver”
means
a
person,
at
least
18
years
of
age,
10
who
has
been
designated
by
a
patient’s
health
care
practitioner
11
or
a
person
having
custody
of
a
patient,
as
a
necessary
12
caretaker
taking
responsibility
for
managing
the
well-being
13
of
the
patient
with
respect
to
the
use
of
medical
cannabis
14
pursuant
to
the
bill.
15
“Written
certification”
means
a
document
signed
by
a
health
16
care
practitioner,
with
whom
the
patient
has
established
a
17
patient-provider
relationship,
which
states
that
the
patient
18
has
a
debilitating
medical
condition
and
provides
any
other
19
relevant
information.
20
HEALTH
CARE
PRACTITIONER
CERTIFICATION.
The
bill
provides
21
that
prior
to
a
patient’s
submission
of
an
application
22
for
a
medical
cannabis
registration
card,
if
a
health
care
23
practitioner
determines
that
the
patient
whom
the
health
24
care
practitioner
has
examined
and
treated
suffers
from
a
25
debilitating
medical
condition,
the
health
care
practitioner
26
may
provide
the
patient
with
a
written
certification
of
that
27
diagnosis.
If
the
health
care
practitioner
provides
the
28
written
certification,
the
practitioner
must
also
provide
29
explanatory
information
to
the
patient
about
the
therapeutic
30
use
of
medical
cannabis,
and
if
the
patient
continues
to
suffer
31
from
a
debilitating
medical
condition,
issue
the
patient
a
new
32
certification
of
that
diagnosis
on
an
annual
basis.
33
MEDICAL
CANNABIS
REGISTRATION
CARD
——
PATIENT
AND
PRIMARY
34
CAREGIVER.
The
department
may
approve
the
issuance
of
a
35
-16-
LSB
2576XC
(4)
86
rh/rj
16/
23
S.F.
_____
medical
cannabis
registration
card
by
the
department
of
1
transportation
to
a
patient
who
is
at
least
18
years
of
age
and
2
is
a
permanent
resident
of
this
state,
who
submits
a
written
3
certification
by
the
patient’s
health
care
practitioner
to
the
4
department,
and
who
submits
an
application
to
the
department
5
of
public
health
with
certain
information.
The
department
6
of
public
health
may
also
approve
the
issuance
of
a
medical
7
cannabis
registration
card
by
the
department
of
transportation
8
to
a
primary
caregiver
who
is
at
least
18
years
of
age,
9
submits
a
written
certification
by
the
patient’s
health
care
10
practitioner
to
the
department
on
behalf
of
the
patient,
11
and
submits
an
application
to
the
department
with
certain
12
information.
A
medical
cannabis
registration
card
expires
one
13
year
after
the
date
of
issuance
and
may
be
renewed.
14
MEDICAL
ADVISORY
BOARD.
The
director
of
public
health
is
15
directed
to
establish
a
medical
advisory
board,
no
later
than
16
August
15,
2015,
to
consist
of
nine
practitioners
representing
17
the
fields
of
neurology,
pain
management,
gastroenterology,
18
oncology,
psychiatry,
infectious
disease,
family
medicine,
19
gynecology,
and
pharmacy.
The
practitioners
shall
be
20
nationally
board-certified
in
their
area
of
specialty
and
21
knowledgeable
about
the
use
of
medical
cannabis.
The
duties
of
22
the
board
include
reviewing
and
recommending
to
the
department
23
for
approval
additional
chronic
or
debilitating
diseases
or
24
medical
conditions
or
their
treatments
as
debilitating
medical
25
conditions
that
qualify
for
the
use
of
medical
cannabis
under
26
the
bill,
accepting
and
reviewing
petitions
to
add
chronic
or
27
debilitating
diseases
or
medical
conditions
or
their
treatments
28
to
the
list
of
debilitating
medical
conditions
that
qualify
29
for
the
use
of
medical
cannabis
under
the
bill,
and
advising
30
the
department
regarding
the
location
of
medical
cannabis
31
dispensaries,
the
form
and
quantity
of
allowable
medical
32
cannabis
to
be
dispensed
to
a
patient
or
primary
caregiver,
and
33
the
general
oversight
of
medical
cannabis
manufacturers
and
34
medical
cannabis
dispensaries.
35
-17-
LSB
2576XC
(4)
86
rh/rj
17/
23
S.F.
_____
MEDICAL
CANNABIS
MANUFACTURER
LICENSURE.
The
bill
1
requires
the
department
to
license
four
medical
cannabis
2
manufacturers
for
the
manufacture
of
medical
cannabis
within
3
this
state
by
December
1,
2015,
and
to
license
new
medical
4
cannabis
manufacturers
or
relicense
existing
medical
cannabis
5
manufacturers
by
December
1
of
each
year.
Information
6
submitted
during
the
application
process
is
confidential
7
until
the
medical
cannabis
manufacturer
is
licensed
by
the
8
department
unless
otherwise
protected
from
disclosure
under
9
state
or
federal
law.
As
a
condition
for
licensure,
a
medical
10
cannabis
manufacturer
must
agree
to
begin
supplying
medical
11
cannabis
to
patients
by
July
1,
2016.
The
department
is
12
directed
to
consider
several
factors
in
determining
whether
to
13
license
a
medical
cannabis
manufacturer
including
technical
14
expertise,
employee
qualifications,
financial
stability,
15
security
measures,
and
production
needs
and
capacity.
Each
16
medical
cannabis
manufacturer
is
required
to
contract
with
the
17
state
hygienic
laboratory
at
the
university
of
Iowa
to
test
the
18
medical
cannabis
produced
by
the
manufacturer
and
to
report
19
testing
results
to
the
medical
cannabis
manufacturer.
Each
20
entity
submitting
an
application
for
licensure
shall
pay
an
21
application
fee
of
$7,500.
22
MEDICAL
CANNABIS
MANUFACTURERS
——
MEDICAL
CANNABIS
23
DISPENSARIES.
The
bill
requires
a
medical
cannabis
24
manufacturer
to
operate
three
medical
cannabis
dispensaries
in
25
this
state.
A
medical
cannabis
manufacturer
is
required
to
26
begin
dispensing
medical
cannabis
from
at
least
one
medical
27
cannabis
dispensary
by
July
1,
2016.
The
medical
cannabis
28
dispensaries
shall
be
located
based
on
geographical
need
29
throughout
the
state
to
improve
patient
access.
A
medical
30
cannabis
manufacturer
shall
operate
only
one
location
where
31
all
manufacturing
and
cultivating,
harvesting,
packaging,
and
32
processing
shall
be
conducted.
The
other
medical
cannabis
33
dispensaries
may
dispense
medical
cannabis
pursuant
to
the
34
provisions
of
the
bill
but
shall
not
dispense
any
medical
35
-18-
LSB
2576XC
(4)
86
rh/rj
18/
23
S.F.
_____
cannabis
in
a
form
or
quantity
other
than
the
form
or
quantity
1
allowed
by
the
department
pursuant
to
rule.
2
The
operating
documents
of
a
medical
cannabis
manufacturer
3
shall
include
procedures
for
oversight
and
recordkeeping
4
activities
of
the
medical
cannabis
manufacturer
and
security
5
measures
undertaken
by
the
medical
cannabis
manufacturer.
6
A
medical
cannabis
manufacturer
is
prohibited
from
sharing
7
office
space
with,
referring
patients
to,
or
having
a
financial
8
relationship
with
a
health
care
practitioner,
permitting
any
9
person
to
consume
medical
cannabis
on
the
property
of
the
10
medical
cannabis
manufacturer,
employing
a
person
who
is
under
11
21
years
of
age
or
who
has
been
convicted
of
a
disqualifying
12
felony
offense,
and
from
operating
in
any
location,
whether
13
for
dispensing
or
for
manufacturing,
cultivating,
harvesting,
14
packaging,
and
processing,
within
1,000
feet
of
a
public
or
15
private
school
existing
before
the
date
of
the
medical
cannabis
16
manufacturer’s
licensure.
A
medical
cannabis
manufacturer
17
shall
be
subject
to
reasonable
inspection
and
shall
be
subject
18
to
reasonable
restrictions
relating
to
signage,
marketing,
19
display,
and
advertising
of
the
medical
cannabis.
20
MEDICAL
CANNABIS
MANUFACTURER
——
PRODUCTION
AND
21
DISPENSATION.
A
medical
cannabis
manufacturer
is
required
to
22
provide
a
reliable
and
ongoing
supply
of
medical
cannabis
for
23
all
patients
served
pursuant
to
the
provisions
of
the
bill,
24
and
all
manufacturing,
cultivating,
harvesting,
packaging,
and
25
processing
of
medical
cannabis
is
required
to
take
place
in
an
26
enclosed,
locked
facility
at
a
physical
address
provided
to
the
27
department
during
the
licensure
process.
28
Prior
to
the
dispensing
of
any
medical
cannabis,
the
medical
29
cannabis
manufacturer
is
required
to
verify
that
the
medical
30
cannabis
manufacturer
has
received
a
valid
medical
cannabis
31
registration
card
from
a
patient
or
a
patient’s
primary
32
caregiver,
if
applicable,
assign
a
tracking
number
to
any
33
medical
cannabis
dispensed
from
the
manufacturer,
and
properly
34
package
and
label
medical
cannabis
in
compliance
with
the
35
-19-
LSB
2576XC
(4)
86
rh/rj
19/
23
S.F.
_____
provisions
of
the
bill
and
certain
federal
laws.
1
CONFIDENTIALITY.
The
department
is
required
to
maintain
2
a
confidential
file
of
the
names
of
each
patient
and
primary
3
caregiver
issued
a
medical
cannabis
registration
card.
4
Individual
names
contained
in
the
file
shall
be
confidential
5
and
shall
not
be
subject
to
disclosure,
except
that
information
6
in
the
confidential
file
may
be
released
on
an
individual
7
basis
to
authorized
employees
or
agents
of
the
department,
8
the
department
of
transportation,
and
a
medical
cannabis
9
manufacturer
as
necessary
to
perform
their
duties
and
to
10
authorized
employees
of
state
or
local
law
enforcement
agencies
11
for
the
purpose
of
verifying
that
a
person
is
lawfully
in
12
possession
of
a
medical
cannabis
registration
card.
Release
13
of
information
must
also
be
consistent
with
federal
Health
14
Insurance
Portability
and
Accountability
Act
regulations.
15
ADDITIONAL
DEPARTMENT
DUTIES
——
RULES.
The
bill
requires
16
the
department
to
adopt
rules
relating
to
the
manner
in
which
17
the
department
shall
consider
applications
for
new
and
renewal
18
medical
cannabis
registration
cards,
identify
criteria
and
19
set
forth
procedures
for
including
additional
chronic
or
20
debilitating
diseases
or
medical
conditions
or
their
medical
21
treatments
on
the
list
of
debilitating
medical
conditions,
22
establish
the
form
and
quantity
of
medical
cannabis
allowed
to
23
be
dispensed
to
a
patient
or
primary
caregiver
in
the
form
and
24
quantity
appropriate
to
serve
the
medical
needs
of
the
patient
25
with
the
debilitating
medical
condition,
establish
requirements
26
for
the
licensure
of
medical
cannabis
manufacturers,
develop
27
a
dispensing
system
for
medical
cannabis
within
this
state
28
that
follows
certain
requirements,
establish
medical
cannabis
29
registration
card
application
and
renewal
fees,
and
specify
30
and
implement
procedures
that
address
public
safety
including
31
security
procedures
and
product
quality,
safety,
and
labeling.
32
RECIPROCITY.
The
bill
provides
that
a
valid
medical
33
cannabis
registration
card,
or
its
equivalent,
issued
under
34
the
laws
of
another
state
that
allows
an
out-of-state
patient
35
-20-
LSB
2576XC
(4)
86
rh/rj
20/
23
S.F.
_____
to
possess
or
use
medical
cannabis
in
the
jurisdiction
of
1
issuance
shall
have
the
same
force
and
effect
as
a
valid
2
medical
cannabis
card
issued
under
the
bill,
except
that
an
3
out-of-state
patient
in
this
state
shall
not
obtain
medical
4
cannabis
from
a
medical
cannabis
dispensary
in
this
state.
5
USE
OF
MEDICAL
CANNABIS
——
SMOKING
PROHIBITED.
The
bill
6
provides
that
a
patient
shall
not
consume
the
medical
cannabis
7
by
smoking
the
medical
cannabis.
8
USE
OF
MEDICAL
CANNABIS
——
AFFIRMATIVE
DEFENSES.
The
bill
9
provides
prosecution
immunity
for
a
health
care
practitioner,
10
a
medical
cannabis
manufacturer,
and
a
medical
cannabis
11
dispensary,
including
any
authorized
agents
or
employees
of
the
12
health
care
practitioner,
medical
cannabis
manufacturer,
and
13
medical
cannabis
dispensary,
for
activities
undertaken
by
the
14
health
care
practitioner,
medical
cannabis
manufacturer,
and
15
medical
cannabis
dispensary
pursuant
to
the
provisions
of
the
16
bill.
17
The
bill
provides
that
in
a
prosecution
for
the
unlawful
18
possession
of
marijuana
under
the
laws
of
this
state,
19
including
but
not
limited
to
Code
chapters
124
(controlled
20
substances)
and
453B
(excise
tax
on
unlawful
dealing
in
21
certain
substances),
it
is
an
affirmative
and
complete
22
defense
to
the
prosecution
that
the
patient
has
been
diagnosed
23
with
a
debilitating
medical
condition,
used
or
possessed
24
medical
cannabis
pursuant
to
a
certification
by
a
health
25
care
practitioner,
and,
for
a
patient
age
18
or
older,
is
26
in
possession
of
a
valid
medical
cannabis
registration
27
card.
The
bill
provides
a
similar
affirmative
defense
for
a
28
primary
caretaker
of
a
patient
who
has
been
diagnosed
with
a
29
debilitating
medical
condition
who
is
in
possession
of
a
valid
30
medical
cannabis
registration
card,
and
where
the
primary
31
caregiver’s
possession
of
the
medical
cannabis
is
on
behalf
of
32
the
patient
and
for
the
patient’s
use
only.
33
The
bill
amends
Code
section
124.401,
relating
to
prohibited
34
acts
involving
controlled
substances,
to
provide
that
it
is
35
-21-
LSB
2576XC
(4)
86
rh/rj
21/
23
S.F.
_____
lawful
for
a
person
to
knowingly
or
intentionally
recommend,
1
possess,
use,
dispense,
deliver,
transport,
or
administer
2
medical
cannabis
if
the
recommendation,
possession,
use,
3
dispensing,
delivery,
transporting,
or
administering
is
in
4
accordance
with
the
provisions
of
the
bill.
5
The
bill
provides
that
an
agency
of
this
state
or
a
political
6
subdivision
thereof,
including
any
law
enforcement
agency,
7
shall
not
remove
or
initiate
proceedings
to
remove
a
patient
8
under
the
age
of
18
from
the
home
of
a
parent
based
solely
upon
9
the
parent’s
or
patient’s
possession
or
use
of
medical
cannabis
10
as
authorized
under
the
bill.
11
PENALTIES.
The
bill
provides
that
a
person
who
knowingly
or
12
intentionally
possesses
or
uses
medical
cannabis
in
violation
13
of
the
requirements
of
the
bill
is
subject
to
the
penalties
14
provided
under
Code
chapters
124
and
453B.
In
addition,
a
15
medical
cannabis
manufacturer
shall
be
assessed
a
civil
penalty
16
of
up
to
$1,000
per
violation
for
any
violation
of
the
bill
in
17
addition
to
any
other
applicable
penalties.
18
EMERGENCY
RULES.
The
bill
provides
that
the
department
19
may
adopt
emergency
rules
and
the
rules
shall
be
effective
20
immediately
upon
filing
unless
a
later
date
is
specified
in
the
21
rules.
22
TRANSITION
PROVISIONS.
The
bill
provides
that
a
medical
23
cannabis
registration
card
issued
under
Code
chapter
124D
24
(medical
cannabidiol
Act)
prior
to
July
1,
2015,
shall
remain
25
effective
and
continues
in
effect
as
issued
for
the
12-month
26
period
following
its
issuance.
27
REPORTS.
The
bill
requires
the
university
of
Iowa
Carver
28
college
of
medicine
and
college
of
pharmacy
to,
on
or
before
29
July
1
of
each
year,
beginning
July
1,
2016,
submit
a
report
30
detailing
the
scientific
literature,
studies,
and
clinical
31
trials
regarding
the
use
of
medical
cannabis
on
patients
32
diagnosed
with
debilitating
medical
conditions
as
defined
in
33
the
bill
to
the
department
of
public
health
and
the
general
34
assembly.
35
-22-
LSB
2576XC
(4)
86
rh/rj
22/
23
S.F.
_____
REPEAL.
The
bill
repeals
Code
chapter
124D,
the
medical
1
cannabidiol
Act.
2
-23-
LSB
2576XC
(4)
86
rh/rj
23/
23